Ola Spjuth vid institutionen för farmaceutisk biovetenskap har tilldelats 2.9 M SEK för att leda ett work-package i EU Horizon 2020 projektet OpenRiskNet. Projektet startade 2016-12-01 och kommer att utveckla molnbaserade virtuella forskningsmiljöer för att stödja olika aspekter inom säkerhetsbedömning och produktutveckling med t ex kemiska, farmaceutiska och kosmetiska applikationer. Den utvecklade e-infrastrukturen kommer att erbjuda funktioner för smart integration av heterogena datorkällor, samt för implementation och exekvering av skalbara dataanalyser och pipelines.
The department is part of the only Faculty of Pharmacy in Sweden. We aim to provide an international and stimulating environment where researchers, teachers, postgraduate students, visiting researchers, students, technical and administrative staff can work together on issues relevant to future pharmaceutical drug development. Our education and research are conducted within several fields of modern life science. We also offer many courses and programmes!
All research is undertaken with the overall aim of increasing the knowledge about mechanisms of actions, kinetics and side-effects of pharmaceutical drugs in order to promote the development of effective and safe drugs. We are organised in a number of research groups working from the molecular level to population level and within several different disciplines. Teaching at the Department is conducted by professors, senior and junior lecturers as well as researchers and PhD students. The Department is centrally located within the large Uppsala University Biomedical Centre (BMC) and has around 110 employees as well as many scholarship holders and visiting researchers.
We are cooperating nationally and internationally with many universities and pharmaceutical drug companies in order to improve drug development and management as the basis for drug efficiency and safety.